health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl and other opioids driving the nation's drug crisis.

.

. The New Drug Application (NDA) is the formal step the manufacturer takes to ask that the FDA to approve their drug for US marketing.

First published on Fri 6 Jan 2023 14.

.

. S. In 2022, the US Food and Drug Administration approved 37 novel drugs, down from 50 in 2021 and 53 in 2020.

Rinvoq is the first approved oral product available to treat moderately to severely active Crohn’s disease.

health regulators on Monday approved a new, easy-to. S. Below is a listing of new molecular entities and new therapeutic biological products that CDER approved in 2021.

Veozah (fezolinetant) Tablets. Indivior via AP.

S.

.

Opvee. Rinvoq is the first approved oral product available to treat moderately to severely active Crohn’s disease.

. Today, the U.

.
S.
Food and Drug Administration approved Xacduro (sulbactam for injection; durlobactam for injection), a new treatment for hospital-acquired bacterial pneumonia (HABP.

Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose.

.

May 12, 2023 · Astellas said that the drug would cost $550 for a 30-day supply, not including rebates. . This initial stage includes discovery and development of prototypes involving preclinical and clinical studies of new drug materials to be reviewed and approved by an institutional review board (IRB).

. . S. . . 2 days ago · WASHINGTON — U.

.

S. S.

.

.

.

May 12, 2023 · The FDA approved on Friday a new nonhormonal medication to treat hot flashes and night sweats caused by menopause.

Following the 12.